Predictive Value of Infarction Volume on Hemorrhagic Transformation in Ischemic Stroke/TIA With Non-valve Atrial Fibrillation(NVAF) Patients Using Rivaroxaban

Clinical trial NCT03772457 · UNKNOWN

Trial details

NCT number: NCT03772457
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: UNKNOWN
Study type: OBSERVATIONAL

Cerebrovascular Stroke Intracranial Hemorrhages Anticoagulant Matrix Metalloproteinases

Start date: 2019-01-18
Primary completion: 2023-12-31
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.